Sunshine Biopharma, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SBFM | RDHL | UPC | CPIX | LFCR | AQST | |
|---|---|---|---|---|---|---|
| Market cap | 1.30M | 4.74M | 20.75M | 104.88M | 244.11M | 603.71M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | 0.0 | 17.8 | — | 50.0 | -8.3 | -8.4 |
| Price/book | 0.0 | 0.6 | 0.0 | 6.0 | -7.1 | -10.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −97.83% | −66.93% | −34.96% | +107.10% | −2.42% | −30.09% |
| Today | −10.60% | −1.04% | −0.48% | −0.43% | −0.16% | +0.63% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All SBFM news ›Sunshine Biopharma Completes $6 Million Public Offering
Sunshine Biopharma ( (SBFM) ) has provided an update. Spark’s Take on SBFM Stock According to Spark, TipRanks’ AI Analyst, SBFM is a Neutral. More about Sunshine Biopharma Current Market Cap: $3.02M For detailed information about SBFM…
Sunshine Biopharma, Inc. (NASDAQ:SBFM) Sees Significant Growth in Short Interest
Sunshine Biopharma, Inc. (NASDAQ:SBFM – Get Free Report) saw a significant increase in short interest during the month of September. As of September 30th, there was short interest totaling 131,478 shares, an increase of 461.6% from the…
Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering
$6.0 million upfront with an additional $14.4 million of potential aggregate gross proceeds upon the exercise of warrants Gross proceeds to the Company were approximately $6.0 million. The potential additional gross proceeds to the Company…
Sunshine Biopharma announces pricing of $6M public offering
Sunshine Biopharma (SBFM) priced a $6M public offering at $0.55/unit with Series D warrants, closing Oct. 9. - Sunshine Biopharma (SBFM) on Thursday announced the pricing of a public offering made on a reasonable best efforts basis with…
SBFM Stock Pops As Sunshine Biopharma Pushes Antiviral, Generics
Sunshine Biopharma Inc. stocks have been trading up by 47.13 percent amid heightened optimism surrounding its latest biotech developments. SBFM has been trading like a classic low-priced biotech with a news catalyst. In the multi-day…
Avalon Pharma secures exclusive rights to market Tirzepatide
Avalon Pharma can request the transfer of manufacturing technology after the product’s commercial launch. Middle East Pharmaceutical Industries Co. (Avalon Pharma) signed a licensing agreement with OneSource Specialty Pharma Ltd., granting…
Enoumena Therapeutics and AOP Health Announce Exclusive Canadian Commercialization Agreement for SIBBORAN(R) (landiolol)
Montreal, Quebec and Vienna, Austria--(Newsfile Corp. - October 8, 2026) - Enoumena Therapeutics Inc. and AOP Health today announced an exclusive commercialization agreement to expand Canadian institutional access to PrSIBBORAN®…
Sunshine Biopharma: Alta reports 4.905% stake
Warrants for 200,000 shares feature in Alta’s amended Sunshine Biopharma (SBFM) stake report. Stock Titan - [SCHEDULE 13G/A] Sunshine Biopharma Inc. Amended Passive Investment Disclosure Sunshine Biopharma: Alta reports 4.905% stake…
Orimed Pharma launches PrBALANSYA®, Canada's only escitalopram oral solution
BOUCHERVILLE, QC, Oct. 1, 2026 /CNW/ -- Orimed Pharma, a Canadian-owned pharmaceutical company within the JAMP Pharma Group, announces the launch of PrBALANSYA, Canada's only escitalopram oral solution.1 The launch expands Orimed's liquid…
Head to Head Contrast: ANI Pharmaceuticals (NASDAQ:ANIP) and Sunshine Biopharma (NASDAQ:SBFM)
Posted by Sarita Garza on Sep 30th, 2026 ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) and Sunshine Biopharma (NASDAQ:SBFM – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
digitaljournal.com3
-
stocktitan.net2
-
argaam.com1
-
biospace.com1
-
defenseworld.net1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.